ADIPOQ and type 2 diabetes mellitus: In fact, low serum adiponectin concentration has been reported to be a risk factor for the development of T2D in many populations, and, therefore, serum adiponectin concentration has been used to evaluate the risk for future development of T2D in non-diabetic populations [6,7,8,9].